| mRNA |
16-beta-bromoandrosterone |
CTRPv2 |
pan-cancer |
AAC |
-0.0033 |
0.9 |
| mRNA |
sirolimus:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.0029 |
0.9 |
| mRNA |
MLN4924 |
CTRPv2 |
pan-cancer |
AAC |
0.0028 |
0.9 |
| mRNA |
ML334 diastereomer |
CTRPv2 |
pan-cancer |
AAC |
-0.0036 |
0.9 |
| mRNA |
BRD-K88742110 |
CTRPv2 |
pan-cancer |
AAC |
-0.0029 |
0.9 |
| mRNA |
Fumonisin B1 |
CTRPv2 |
pan-cancer |
AAC |
0.0028 |
0.9 |
| mRNA |
968 |
CTRPv2 |
pan-cancer |
AAC |
-0.0051 |
0.9 |
| mRNA |
EX-527 |
CTRPv2 |
pan-cancer |
AAC |
0.0028 |
0.9 |
| mRNA |
BRD-K85133207 |
CTRPv2 |
pan-cancer |
AAC |
-0.0026 |
0.9 |
| mRNA |
PF-184 |
CTRPv2 |
pan-cancer |
AAC |
0.0022 |
0.9 |